Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2021-12-22 Share Issue/Capital Cha…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于2020年限制性股票激励计划第一个归属期归属结果暨股份上市的公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the first vesting results and listing of shares under the 2020 restricted stock incentive plan. It includes specifics about the number of shares vested, the number of incentive recipients, the vesting conditions, legal opinions, and the impact on share capital structure. The document is not a full annual or interim financial report but rather a corporate announcement about stock incentive plan implementation and share issuance related to management and employees. It does not contain comprehensive financial statements or earnings highlights but focuses on share issuance and management incentives. This fits best under the category of Share Issue/Capital Change (SHA), as it announces the issuance and listing of restricted shares as part of a stock incentive plan.
2021-12-22 Chinese
关于召开2021年第三次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2021 third extraordinary general meeting (临时股东大会) of Guangzhou Yangpu Medical Technology Co., Ltd. It includes information about the meeting date, voting procedures, registration details, proposals to be voted on (such as the election of board members), and proxy forms. It does not contain financial statements or results but is focused on informing shareholders about the meeting and how to participate and vote. This matches the definition of a Proxy Solicitation & Information Statement (PSI), which are materials sent to shareholders to provide information and request votes for meetings. The document length is 4260 characters, which is consistent with a detailed meeting notice rather than a full report or announcement of results. Therefore, the correct classification is PSI.
2021-12-15 Chinese
关于改选公司董事会成员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the re-election of members of the company's board of directors. It details changes in board membership, including resignations and new nominations, along with brief biographies of the new nominees. There is no financial data, earnings information, or report publication mentioned. The content clearly relates to changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is short and focused solely on board member changes, confirming it is not a full report or other type of filing.
2021-12-15 Chinese
独立董事关于第五届董事会第十五次会议相关事项的独立意见
Regulatory Filings Classification · 95% confidence The document is an independent opinion from the independent directors of Guangzhou Yangpu Medical Technology Co., Ltd. regarding matters related to the 15th meeting of the 5th Board of Directors. It discusses the nomination and qualifications of board candidates and confirms compliance with relevant laws and company regulations. There is no financial data, no report publication, no voting results, no management changes announcement, and no regulatory certification. The document is a formal opinion related to board matters but does not announce a change or provide detailed management information. It fits best under Regulatory Filings (RNS) as a formal regulatory disclosure that does not fit other categories.
2021-12-15 Chinese
第五届董事会第十五次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of the resolutions passed at a board meeting, specifically about the re-election of board members and the scheduling of a shareholders' meeting to approve these changes. It includes details about the board meeting process, voting results, and biographies of the proposed new directors. There are no financial statements or detailed financial data presented. The document is a formal announcement related to changes in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report or presentation but an official announcement of board changes.
2021-12-15 Chinese
关于广州阳普医疗科技股份有限公司公司债券的临时受托管理事务报告(1)
Audit Report / Information Classification · 95% confidence The document is titled as a '临时受托管理事务报告' which translates to 'Temporary Trustee Management Affairs Report' related to company bonds issued by Guangzhou Yangpu Medical Technology Co., Ltd. It details bond issuance background, bond trustee responsibilities, and significant shareholder changes affecting control of the company. The document is prepared by the bond trustee (China Securities Co., Ltd.) and focuses on bond management and shareholder structure changes impacting bondholders. It does not contain full financial statements or comprehensive financial performance data typical of Annual or Interim Reports. It is not an announcement of voting results, nor a call transcript or capital update. The document is a standalone report related to bond trustee management and bondholder interests, fitting the definition of an Audit Report / Information (AR) category, which includes reports on applied accounting principles, internal or regulatory stress tests, or trustee reports related to bonds. The document length is 4033 characters, which is sufficient for a substantive report rather than a brief announcement. Therefore, the best classification is AR with high confidence. FY 2021
2021-12-15 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.